Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
CH PHARMACONSULTING from Sint-Pieters-Woluwe, company number BE0780468928, closed financial year 2025 with a result of € -27,517 after tax. For that financial year CH PHARMACONSULTING recorded a gross margin of € -5,711 and equity of € 40,857. Compared with financial year 2024, the result moved from € -20,976 to € -27,517. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 2, 2026.
€ 40,857
▼ 40% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -27,517
▼ 31 % more loss than in 2024
Profit after tax over the fiscal year.
€ 1,593
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 37,857.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
€ 172
▼ 94% vs 2024
Loans from banks and other lenders, long and short.
€ 4,637
▲ € 3,551 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 523
▲ 54% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 114,187 | € 23,440 | € -13,060 | € -5,711 | ▲ € 7,349 |
| Profit after taxes | € 86,591 | € -241 | € -20,976 | € -27,517 | ▼ € 6,541 |
| Equity | € 89,591 | € 89,350 | € 68,373 | € 40,857 | ▼ 40% |
| Total debts | € 5,603 | € 520 | € 4,458 | € 5,333 | ▲ 20% |
| Cash | € 58,768 | € 11,297 | - | € 1,593 | |
| Retained profit | € 86,591 | € 86,350 | € 65,373 | € 37,857 | ▼ 42% |
| Bank debt | € 753 | € 300 | € 3,031 | € 172 | ▼ 94% |
| Balance sheet total | € 95,194 | € 89,870 | € 72,832 | € 46,189 | ▼ 37% |
Key figures of CH PHARMACONSULTING, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about CH PHARMACONSULTING the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to CH PHARMACONSULTING?
What happened at CH PHARMACONSULTING in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 27,517. Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Sint-Pieters-Woluwe. KBO
In short
From € 86,591 profit in 2022 to € 27,517 loss in 2025.
Paid € 25,208 in corporate taxes since 2022.
Best year ever: 2022, with € 86,591 profit.
Management
Behind CH PHARMACONSULTING is Julien Colot.
Directors
According to the 2025 annual accounts
Julien Colot
Director
Establishments
Establishment units
Physical locations of this company
Atlantische Oceaanlaan 53
1150 Sint-Pieters-Woluwe
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- CHAABANE Hanène(Actionnaire fondateur) 100%
Details
- Company number
- 0780.468.928
- VAT number
- BE 0780.468.928
- Registered office
- Atlantische Oceaanlaan 53, 1150 Sint-Pieters-Woluwe
- Names & denominations
- CH PHARMACONSULTING
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 January 2022
- Peppol
- Active · Active since 9 Jan 2026
- Activities · NACE
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten